he US onychomycosis market (prescription drugs) has increased with a healthy growth rate over the years and is expected to increase further during the forecasted period. The US onychomycosis market is supported by various growth drivers, such as rising per capita healthcare expenditure, increasing diabetic patients, ageing population, introduction of new drugs, etc. Yet, the market faces certain challenges, such as, reimbursements, low awareness, side effects, etc. Purchase a copy of this "The US Onychomycosis Market (2017 Edition)" research report at USD 750 (Single User License) http://www.marketreportsonline.com/contacts/purchase.php?name=616679.
http://bit.ly/2wlOrsm